Thursday, February 12, 2026 | 01:24 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sanket Koul

Sanket Koul

Sanket Koul

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Email

Page 26 - Sanket Koul

A day after Delhi came on board, Ayushman Bharat training for staff begins

State government aims to meet 30-day targets in card creation, PHC upgradation

A day after Delhi came on board, Ayushman Bharat training for staff begins
Updated On : 21 Feb 2025 | 9:15 PM IST

Govt extends Rajeev Singh Raghuvanshi's tenure as DCGI by one year

Raghuvanshi, who took charge as DCGI on February 23, 2023, was initially set to superannuate on February 28 this year

Govt extends Rajeev Singh Raghuvanshi's tenure as DCGI by one year
Updated On : 21 Feb 2025 | 6:23 PM IST

Govt asks IVD kit makers to report adverse events; aims to collate info

Releases draft format for adverse events for rapid identification and rectification of potential device failures

Govt asks IVD kit makers to report adverse events; aims to collate info
Updated On : 20 Feb 2025 | 12:05 AM IST

Manohar Lal Khattar opens Delhi Metro's first vertical solar plant

DMRC targets 60 MW solar power plant capacity by end of its Phase-IV projects

Manohar Lal Khattar opens Delhi Metro's first vertical solar plant
Updated On : 18 Feb 2025 | 7:46 PM IST

Top private hospitals plan capacity expansion with focus on oncology

Rising demand for cancer beds, healthy growth signs in ARPOB fuel expansion plans

Top private hospitals plan capacity expansion with focus on oncology
Updated On : 17 Feb 2025 | 10:47 PM IST

Manufacturers asked to revise MRP for drugs with nil, reduced customs duty

In her budget speech, Finance Minister Nirmala Sitharaman announced the exemption of 36 drugs used to treat cancer, rare diseases, and other severe chronic diseases from the basic customs duty

Manufacturers asked to revise MRP for drugs with nil, reduced customs duty
Updated On : 17 Feb 2025 | 7:46 PM IST

Kumbh devotees count their dead as crowd fails to reduce at NDLS

"If you think this is crowded, yesterday's sights would have horrified you," said a vendor at Platform 16 - first platform upon entry as one makes their way in through Ajmeri Gate complex of station

Kumbh devotees count their dead as crowd fails to reduce at NDLS
Updated On : 16 Feb 2025 | 11:59 PM IST

Rlys scrambles into action after stampede kills 18 at New Delhi station

All Prayagraj special trains to now leave from Platform 16

Rlys scrambles into action after stampede kills 18 at New Delhi station
Updated On : 16 Feb 2025 | 10:52 PM IST

Fortis Healthcare to acquire 228 bed hospital in Punjab for Rs 462 crore

Move aims to strengthen chain's Punjab cluster with over 1,000 beds

Fortis Healthcare to acquire 228 bed hospital in Punjab for Rs 462 crore
Updated On : 14 Feb 2025 | 8:37 PM IST

GlaxoSmithKline Pharma Q3FY25: Net profit rises 400% to Rs 228.58 crore

The performance is attributed to the company's strong growth across key product portfolios

GlaxoSmithKline Pharma Q3FY25: Net profit rises 400% to Rs 228.58 crore
Updated On : 14 Feb 2025 | 7:32 PM IST

Govt to spend Rs 3,200 crore on cancer centres in all district hospitals

DHR gets special enhancement of Rs 531 crore for first year of ICMR's five-year strategic plan

Govt to spend Rs 3,200 crore on cancer centres in all district hospitals
Updated On : 13 Feb 2025 | 11:02 PM IST

Over 8.5K MSME pharma units get 1-yr breather to adopt Schedule M standards

Mohfw notifies extension till December 31 for companies under Rs 250 cr turnover

Over 8.5K MSME pharma units get 1-yr breather to adopt Schedule M standards
Updated On : 13 Feb 2025 | 12:16 AM IST

Over 650K families may benefit if Delhi joins Ayushman Bharat cover

According to a parliamentary response by the Union Health Ministry in 2023, around 6.5 lakh families in Delhi are eligible

Over 650K families may benefit if Delhi joins Ayushman Bharat cover
Updated On : 12 Feb 2025 | 5:16 PM IST

NITI proposes fee autonomy, infra financing agency for state universities

SPUs are universities established or incorporated by a state act and funded by state governments. Currently, there are 495 SPUs with over 46,000 affiliated institutions in India

NITI proposes fee autonomy, infra financing agency for state universities
Updated On : 10 Feb 2025 | 11:16 PM IST

PG in focus as govt sets target to add 10,000 medical seats this year

Experts bat for equitable regional distribution of seats

PG in focus as govt sets target to add 10,000 medical seats this year
Updated On : 09 Feb 2025 | 11:20 PM IST

Indian pharma market registers over 8% growth in January 2025: Pharmarack

Among them, the cardiac, anti-diabetic, and gastrointestinal therapies saw high value growth of 10.9 per cent, 10.2 per cent, and 6.9 per cent, respectively, driving overall IPM growth

Indian pharma market registers over 8% growth in January 2025: Pharmarack
Updated On : 07 Feb 2025 | 9:12 PM IST

Fixed ceiling, retail prices to ensure affordable cancer drugs: Govt in LS

In response to a parliamentary query, the ministry said that the Department of Pharmaceuticals, through the National Pharmaceutical Pricing Authority (NPPA)

Fixed ceiling, retail prices to ensure affordable cancer drugs: Govt in LS
Updated On : 07 Feb 2025 | 7:50 PM IST

Alkem Laboratories Q3 results: Net profit rises 5.2% to Rs 625 crore

The company's revenue from operations increased to Rs 3,374 crore in Q3 FY25, a marginal 1.5 per cent Y-o-Y rise from Rs 3,324 crore in Q3 FY24

Alkem Laboratories Q3 results: Net profit rises 5.2% to Rs 625 crore
Updated On : 07 Feb 2025 | 5:46 PM IST

Experts differ on IBBI's move to permit flat possession during insolvency

One major decision in the new amendments is that resolution professionals can hand over possession of plots, apartments, and flats to homebuyers while the insolvency process is ongoing

Experts differ on IBBI's move to permit flat possession during insolvency
Updated On : 06 Feb 2025 | 11:53 PM IST

Aurobindo Pharma Q3FY25 results: PAT falls 10% to Rs 845.56 crore

Company board approves purchase of 80 per cent share in step-down subsidiary Tergene Biotech

Aurobindo Pharma Q3FY25 results: PAT falls 10% to Rs 845.56 crore
Updated On : 06 Feb 2025 | 9:07 PM IST